Fagron

Manufacturer

Audited

Audit report available

Warning letter

Headquarters

Netherlands

Sites

Netherlands

Spain

Poland

Germany

Czech Republic

Issue date

14 Jun 2022

Issuing office

Division of Pharmaceutical Quality Operations III

Posted date

28 Jun 2022

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Products & Services

Drugs